// App-Quantinova.ai

: Real-World Data on the Incidence and Management of Blinatumomab Toxicities in Adult Patients with Minimal Residual Disease and Relapsed or Refractory Acute Lymphoblastic Leukemia

Researchers

Presenter

  • Rebecca Farley

Principal Investigators

  • Eva Karam

  • Xu Zhang

  • Asad Bashey

  • H. Kent Holland

  • Lawrence E. Morris

  • Scott R. Solomon

  • Melhem Solh

Medical Centers

  • Blood and Marrow Transplant Program, Northside Hospital Cancer Institute, Atlanta, GA

  • Center for Clinical and Transitional Sciences, University of Texas Health Science Center, Houston, TX

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Breakpoint Cluster Region

  • Twist-related protein 1

Drug/Treatment

  • Blinatumomab

Outcome

  • N/A

Study Design

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved